Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease

NCT03923543 is registered in ClinicalTrials.gov with Firat Ergin as lead sponsor.

NCT NCT03923543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03923543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease
Lead sponsor
Firat Ergin
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
December 31, 2018
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis newborn